Jefferson Capital appoints two new directors, grants 100K stock options
Filed March 18, 2026 · Period ending March 18, 2026 · ~1 min read
Key Changes
-
medium
Susan Atkins and James Pierce appointed to Board effective March 18, 2026, filling Class II and Class III seats with terms through 2027 and 2028 annual meetings respectively.
Item 5.02 verify on EDGAR → -
medium
Each new director granted options for 50,000 shares: half at current market price, half at market plus $14, vesting equally over three years contingent on continued service.
Item 5.02 verify on EDGAR → -
low
Director Christopher Giles resigned effective immediately to focus on other commitments; filing confirms no disagreement with company operations or policies.
Item 5.02 verify on EDGAR →
This preview is just the start — the full report includes the narrative summary, section-by-section diffs against the prior filing, and verbatim quotes with EDGAR citations.
Want to see a complete report first? Today's free report (SMID 10-Q) is open in full — no account needed.
Partner
Trade JCAP commission-free
Open an account, get a free stock.
Investing involves risk. Free stock terms apply.
Generated by AI · Jun 11, 2026 5:10 AM